Jamie Chaft, MD
Disclosures: Consulting Fee-Genentech (Any division)|Consulting Fee-AstraZeneca (Any division)|Consulting Fee-Merck (Any division)|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Janssen (Any division)|Consulting Fee-Guardant Health|Consulting Fee-Lilly (Any division)|Grant or research support-Novartis Corporation Pharmaceuticals (Relationship has ended)|Grant or research support-Genentech (Any division)|Grant or research support-Bristol-Myers Squibb Company|Grant or research support-AstraZeneca (Any division)|Grant or research support-Merck (Any division)|Grant or research support-BeiGene|Advisor-AstraZeneca (Any division) - 02/01/2024

Jamie E. Chaft, MD is a thoracic medical oncologist and serves as the Director of Early Stage Lung Cancer Research at Memorial Sloan Kettering Cancer Center in NY and NJ. Dr. Chaft’s research focuses on moving therapies that have shown promise in patients with advanced lung cancer into the curative realm, studying drugs preoperatively, postoperatively, and perioperatively, as well as with definitive thoracic radiation.